IMBRIUM THERAPEUTICS
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88977524
- Registration number
- 6076745
- Mark type
- Design + words
- Filed
- 14 Jun 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 09 Jun 2020
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system disorders
Owner
- Purdue Pharma L.P., Stamford, CT, US
- Purdue Pharma L.P., Stamford, CT, US
- Purdue Pharma L.P., Stamford, CT, US
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Apr 2020 — ASSIGNED TO EXAMINER
- 21 Apr 2020 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 20 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Mar 2020 — USE AMENDMENT FILED
- 20 Apr 2020 — DIVISIONAL PROCESSING COMPLETE
- 23 Mar 2020 — DIVISIONAL REQUEST RECEIVED
- 16 Apr 2020 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 16 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2020 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 15 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Mar 2020 — TEAS STATEMENT OF USE RECEIVED